These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3594666)

  • 1. A simplified synthesis of 32-oxygenated lanosterol derivatives.
    Sonoda Y; Tanoue Y; Yamaguchi M; Sato Y
    Chem Pharm Bull (Tokyo); 1987 Jan; 35(1):394-7. PubMed ID: 3594666
    [No Abstract]   [Full Text] [Related]  

  • 2. Sterol synthesis. A simplified method for the synthesis of 32-oxygenated derivatives of 24,25-dihydrolanosterol.
    Parish EJ; Schroepfer GJ
    J Lipid Res; 1981 Jul; 22(5):859-68. PubMed ID: 7288292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antifungal properties of 14-aminomethyl-substituted lanosterol derivatives.
    Cooper AB; Wright JJ; Ganguly AK; Desai J; Loebenberg D; Parmegiani R; Feingold DS
    Ann N Y Acad Sci; 1988; 544():109-12. PubMed ID: 3214062
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis of lanosterol derivatives with a functional group at C-32, including an antineoplastic sterol, 3 beta-hydroxylanost-7-en-32-oic acid.
    Sonoda Y; Ichinose K; Yoshimura T; Sato Y; Sasaki T
    Chem Pharm Bull (Tokyo); 1991 Jan; 39(1):100-3. PubMed ID: 2049792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient routes to epimerically-pure side-chain derivatives of lanosterol.
    Kavtaradze LK; Manley-Harris M; Nicholson BK
    Steroids; 2004 Apr; 69(4):227-33. PubMed ID: 15183688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic studies toward highly functionalized 5beta-lanosterol derivatives: a versatile approach utilizing anionic cycloaddition.
    Ramachandran SA; Kharul RK; Lepage O; Marque S; Soucy P; Jacques F; Chênevert R; Deslongchamps P
    J Org Chem; 2006 Aug; 71(16):6149-56. PubMed ID: 16872199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 32-oxygenated lanosterol derivatives on 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and cholesterol biosynthesis from 24,25-dihydrolanosterol.
    Sonoda Y; Obi N; Onoda M; Sakakibara Y; Sato Y
    Chem Pharm Bull (Tokyo); 1992 Oct; 40(10):2796-9. PubMed ID: 1464112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro effects of oxygenated lanosterol derivatives on cholesterol biosynthesis from 24,25-dihydrolanosterol.
    Sonoda Y; Sekigawa Y; Sato Y
    Chem Pharm Bull (Tokyo); 1988 Mar; 36(3):966-73. PubMed ID: 3409414
    [No Abstract]   [Full Text] [Related]  

  • 9. Ganoderic acid and its derivatives as cholesterol synthesis inhibitors.
    Komoda Y; Shimizu M; Sonoda Y; Sato Y
    Chem Pharm Bull (Tokyo); 1989 Feb; 37(2):531-3. PubMed ID: 2743504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 3-hydroxy group of lanosterol is essential for orienting the substrate site of cytochrome P-450(14DM) (lanosterol 14 alpha- demethylase).
    Aoyama Y; Yoshida Y; Sonoda Y; Sato Y
    Biochim Biophys Acta; 1989 Nov; 1006(2):209-13. PubMed ID: 2688742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of oxygenated lanosterol analogs on cholesterol biosynthesis from lanosterol.
    Sonoda Y; Sato Y
    Chem Pharm Bull (Tokyo); 1983 May; 31(5):1698-701. PubMed ID: 6616720
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparative study of the in vitro and in vivo formation of lanosterol derivatives from acetate by different chick tissues.
    Arce V; Linares A; Aguilera JA; Garcia-Peregrin E
    Biochem Mol Biol Int; 1993 Apr; 29(6):1111-21. PubMed ID: 8330018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Poisoning with a kind of Bitter Edible Gourd].
    Zhonghua Yu Fang Yi Xue Za Zhi; 1983 Jan; 17(1):29-31. PubMed ID: 6851770
    [No Abstract]   [Full Text] [Related]  

  • 14. Equilibration of 24,25-dibromides of lanosterol and derivatives.
    Barton DH; MacGrillen H; Magnus PD; Carlisle CH; Timmins PA
    J Chem Soc Perkin 1; 1972; 12():1584-7. PubMed ID: 5065342
    [No Abstract]   [Full Text] [Related]  

  • 15. Synthesis of lanosterol analogs with lengthened side chains and their effects on cholesterol biosynthesis from lanosterol.
    Sato Y; Sonoda Y
    Chem Pharm Bull (Tokyo); 1984 May; 32(5):1912-8. PubMed ID: 6467473
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthesis of novel 24-amino-25,26,27-trinorlanost-8-enes: cytotoxic and apoptotic potential in U937 cells.
    O'Keeffe R; Kenny O; Brunton NP; Hossain MB; Rai DK; Jones PW; O'Brien N; Maguire AR; Collins SG
    Bioorg Med Chem; 2015 May; 23(9):2270-80. PubMed ID: 25800433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and some reactions of lanosterol. A synthesis of agnosterol.
    Boar RB; Lewis DA; McGhie JF
    J Chem Soc Perkin 1; 1973; 15():1583-8. PubMed ID: 4796392
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of 26-oxygenosterols from Ganoderma lucidum and their activity as cholesterol synthesis inhibitors.
    Hajjaj H; Macé C; Roberts M; Niederberger P; Fay LB
    Appl Environ Microbiol; 2005 Jul; 71(7):3653-8. PubMed ID: 16000773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Bioactive Semisynthetic Derivatives of 31-Norlanostenol and Obtusifoliol from Euphorbia officinarum.
    Bailen M; Khamlichi MD; Benharref A; Martinez-Diaz RA; Gonzalez-Coloma A
    Nat Prod Commun; 2016 Jun; 11(6):733-8. PubMed ID: 27534104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxygenated sterols as inhibitors of enzymatic conversion of dihydrolanosterol into cholesterol.
    Sato Y; Sonoda Y; Morisaki M; Ikekawa N
    Chem Pharm Bull (Tokyo); 1984 Aug; 32(8):3305-8. PubMed ID: 6518607
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.